Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments

BACKGROUND: Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Because current treatment regimens show limited success rates, alternative therapeutic approaches are needed. We recently showed that treatment-naïve, stage I/II primary NSCLC tumors contain a...

Descripción completa

Detalles Bibliográficos
Autores principales: Castenmiller, S.M., de Groot, R., Guislain, A., Monkhorst, K., Hartemink, K.J., Veenhof, A.A.F.A., Smit, E.F., Haanen, J.B.A.G., Wolkers, M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372740/
https://www.ncbi.nlm.nih.gov/pubmed/35965844
http://dx.doi.org/10.1016/j.iotech.2022.100090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372740/
https://www.ncbi.nlm.nih.gov/pubmed/35965844
http://dx.doi.org/10.1016/j.iotech.2022.100090

Ejemplares similares